Literature DB >> 7876892

Glioneuronal malformative lesions and dysembryoplastic neuroepithelial tumors in patients with chronic pharmacoresistant epilepsies.

H K Wolf1, J Wellmer, M B Müller, O D Wiestler, A Hufnagel, T Pietsch.   

Abstract

Malformative glioneuronal lesions were examined in surgical specimens from 43 patients with chronic focal epilepsies in order to determine the scope of histopathological changes and to better understand their pathogenesis. The most common lesions were hamartias composed of randomly oriented neurons and astrocytes (24 cases). Most of these lesions also contained clustered oligodendrocyte-like cells which were often strongly immunoreactive for the developmentally regulated embryonal form of the neural cell adhesion molecule (E-NCAM). These hamartias were typically minute, multifocal, and arranged in a pattern suggestive of a migration disorder. There were eight cases with aggregates of large disfigured neurons, oversized atypical astrocytes and ballooned multinucleated giant cells reminiscent of tuberous sclerosis-associated changes. Finally, there were 11 dysembryoplastic neuroepithelial tumors (DNT), an entity which has been proposed to be malformative rather than neoplastic. The oligodendroglia-like cells in DNT were negative for E-NCAM. However, strong E-NCAM expression was present in many dysplastic neurons of tuberous sclerosis-like lesions, hamartias and DNT and in reactive astrocytes. Significant immunoreactivity for the proliferation associated Ki-67 antigen was not observed. No similar lesions were observed in 500 consecutive autopsies from patients without epilepsy. Malformative glioneuronal lesions appear to be highly epileptogenic and most likely result from a disordered cell migration and differentiation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7876892     DOI: 10.1097/00005072-199503000-00011

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  7 in total

1.  Clinical features and epileptogenesis of dysembryoplastic neuroepithelial tumor.

Authors:  Min-Cheol Lee; Jang-Young Kang; Myung-Bok Seol; Hyung-Seok Kim; Jae-Yeon Woo; Ji-Shin Lee; Shin Jung; Jae-Hyoo Kim; Young-Jong Woo; Myung-Kyu Kim; Hyung-Ihl Kim; Seung-Up Kim
Journal:  Childs Nerv Syst       Date:  2006-08-30       Impact factor: 1.475

Review 2.  Review of seizure outcomes after surgical resection of dysembryoplastic neuroepithelial tumors.

Authors:  Phillip A Bonney; Lillian B Boettcher; Andrew K Conner; Chad A Glenn; Robert G Briggs; Joshua A Santucci; Michael R Bellew; James D Battiste; Michael E Sughrue
Journal:  J Neurooncol       Date:  2015-10-29       Impact factor: 4.130

3.  Dysembryoplastic neuroepithelial tumors: nonspecific histological forms -- a study of 40 cases.

Authors:  C Daumas-Duport; P Varlet; S Bacha; F Beuvon; P Cervera-Pierot; J P Chodkiewicz
Journal:  J Neurooncol       Date:  1999-02       Impact factor: 4.130

4.  Genomic regulatory blocks encompass multiple neighboring genes and maintain conserved synteny in vertebrates.

Authors:  Hiroshi Kikuta; Mary Laplante; Pavla Navratilova; Anna Z Komisarczuk; Pär G Engström; David Fredman; Altuna Akalin; Mario Caccamo; Ian Sealy; Kerstin Howe; Julien Ghislain; Guillaume Pezeron; Philippe Mourrain; Staale Ellingsen; Andrew C Oates; Christine Thisse; Bernard Thisse; Isabelle Foucher; Birgit Adolf; Andrea Geling; Boris Lenhard; Thomas S Becker
Journal:  Genome Res       Date:  2007-03-26       Impact factor: 9.043

5.  Embryonic neuronal markers in tuberous sclerosis: single-cell molecular pathology.

Authors:  P B Crino; J Q Trojanowski; M A Dichter; J Eberwine
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

Review 6.  Genetic basis in epilepsies caused by malformations of cortical development and in those with structurally normal brain.

Authors:  Danielle M Andrade
Journal:  Hum Genet       Date:  2009-06-18       Impact factor: 4.132

7.  Neuropathology of 16p13.11 deletion in epilepsy.

Authors:  Joan Y W Liu; Dalia Kasperavičiūtė; Lillian Martinian; Maria Thom; Sanjay M Sisodiya
Journal:  PLoS One       Date:  2012-04-16       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.